Soy peptide lunasin has anti-cancer, anti-inflammatory properties

Two new University of Illinois studies report that lunasin, a soy peptide often discarded in the waste streams of soy-processing plants, may have important health benefits that include fighting leukemia and blocking the inflammation ...

Update on Golden Retriever Lifetime Study published

As the Morris Animal Foundation Golden Retriever Lifetime Study approaches its 10th anniversary, a newly published paper in the journal PLOS ONE reviews the study's findings to date and previews research in progress. 

The point of no return: Chromatin enforces cell fate decisions

Stem cells balance self-renewal with differentiation into mature cells. A fundamental and intriguing question is when during the process of maturation a cell reaches a "point of no return," losing its capacity to self-renew ...

New insights into the epigenetic control of hematopoiesis

Scientists at The Wistar Institute have characterized a novel function for the INTS13 protein that is part of a large protein complex regulating gene transcription, called Integrator. According to study results, published ...

A breakthrough in nanotoxicology

Whereas resistance to antibiotics complicates certain treatments, antimicrobial silver nanoparticles (AgNP) are gaining popularity for medical use. These particles are toxic for certain bacteria, but what about for humans? ...

Tiny diamonds to boost treatment of chemoresistant leukemia

By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug ...

page 4 from 5